Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy in patients with melanoma from RELATIVITY-020

Ascierto, P. A., Tang, H., Dolfi, S., Nyakas, M., Marie Svane, I., Muñoz-Couselo, E., Grob, J. J., Gomez-Roca, C. A., Chiarion-Sileni, V., Peltola, K., Larkin, J., Melero, I., Callahan, M., Dummer, R., Djidel, P., Warad, D., Reusser-Wolf, D., Lipson, E. J. & Garnett-Benson, C., 25 feb. 2025, I: Journal for ImmunoTherapy of Cancer. 13, 2, 14 s., e009773.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial

Powles, T., Choueiri, T. K., Albiges, L., Peltola, K., de Velasco, G., Burotto, M., Suarez, C., Ghatalia, P., Iacovelli, R., Lam, E. T., Verzoni, E., Gümüş, M., Stadler, W. M., Kollmannsberger, C., Melichar, B., Venugopal, B., Gross-Goupil, M., Poprach, A., De Santis, M. & Rizzo, M., apr. 2025, I: The Lancet Oncology. 26, 4, s. 491-502 12 s.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial

Pakola, S. A., Clubb, J. H. A., Kudling, T., van der Heijden, M., Jirovec, E., Arias, V., Haybout, L., Peltola, K., Alanko, T., Sormunen, J., Pellinen, T., Taipale, K., Quixabeira, D. C. A., Kistler, C., Havunen, R., Sorsa, S., Santos, J. M., Cervera-Carrascon, V. & Hemminki, A., 27 jan. 2025, I: Journal for ImmunoTherapy of Cancer. 13, 1, 15 s., e010493.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

1252P Quantitative cell signaling activity profiling of solid tumors to support personalized treatment in the FINPROVE basket trial

Keizer, D., Niemelä, E., Rozendaal, Y. W., Karjalainen, S., Biezen, E. D., Brussel, A. V. & Mustonen, M., okt. 2023, I: Annals of Oncology. 34, s. S728 1 s.

Forskningsoutput: Tidskriftsbidrag › Mötesabstrakt › Peer review

Single-cell characterization of anti-LAG-3 and anti- PD-1 combination treatment in patients with melanoma

Huuhtanen, J., Kasanen, H., Peltola, K., Lönnberg, T., Glumoff, V., Bruck, O., Dufva, O., Peltonen, K., Vikkula, J., Jokinen, E., Ilander, M., Lee, M. H., Mäkelä, S., Nyakas, M., Li, B., Hernberg, M., Bono, P., Lahdesmaki, H., Kreutzman, A. & Mustjoki, S., 15 mars 2023, I: Journal of Clinical Investigation. 133, 6, 18 s., e164809.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review